INT319663
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
There are also several differences between the activity of CRIF1 and KEAP1; for example, 1) CRIF1 interacts with both the N and C termini of NRF2 protein, whereas KEAP1 interacts with only the N terminus of NRF2; and 2) KEAP1 cannot interact with ETGE point mutants of NRF2, whereas CRIF1 can. | |||||||||||||||
| |||||||||||||||
|
There are also several differences between the activity of CRIF1 and KEAP1; for example, 1) CRIF1 interacts with both the N and C termini of NRF2 protein, whereas KEAP1 interacts with only the N terminus of NRF2; and 2) KEAP1 cannot interact with ETGE point mutants of NRF2, whereas CRIF1 can. | |||||||||||||||
| |||||||||||||||
|
In addition, we found that CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both N- and C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.
| |||||||||||||||
| |||||||||||||||
|
To test whether exogenous CRIF1 can affect NRF2 and NRF2 target gene mRNA levels when functional KEAP1-NRF2 interactions are eliminated, cells were infected with adenovirus (GFP versus GFP-CRIF1) (19) for 24 h and then treated with t-BHQ (100 ? | |||||||||||||||
| |||||||||||||||
|
Two molecules of KEAP1 bind to two distinct sites in the N-terminal region of NRF2, the ETGE and DLG sites, which affect the KEAP1-NRF2 interaction and/or its physiological consequences (1214). | |||||||||||||||
| |||||||||||||||
|
Two molecules of KEAP1 bind to two distinct sites in the N-terminal region of NRF2, the ETGE and DLG sites, which affect the KEAP1-NRF2 interaction and/or its physiological consequences (1214). | |||||||||||||||
| |||||||||||||||
|
In addition, we found that CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both N- and C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.
| |||||||||||||||
| |||||||||||||||
|
There are also several differences between the activity of CRIF1 and KEAP1; for example, 1) CRIF1 interacts with both the N and C termini of NRF2 protein, whereas KEAP1 interacts with only the N terminus of NRF2; and 2) KEAP1 cannot interact with ETGE point mutants of NRF2, whereas CRIF1 can. | |||||||||||||||
| |||||||||||||||
|
Previous studies and our current studies found that KEAP1 interacts only with the most N-terminal region of NRF2 (data not shown) (29). | |||||||||||||||
| |||||||||||||||
|
Previously, it has been shown that NRF2 protein levels increase after oxidative stress because its negative regulator, KEAP1, loses its ability to bind NRF2 and cause its proteasome-mediated degradation during oxidative stress. | |||||||||||||||
| |||||||||||||||
|
To test whether exogenous CRIF1 can affect NRF2 and NRF2 target gene mRNA levels when functional KEAP1-NRF2 interactions are eliminated, cells were infected with adenovirus (GFP versus GFP-CRIF1) (19) for 24 h and then treated with t-BHQ (100 ? | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.